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Deletions in the azoospermia factor (AZF) regions are the most common 
known molecular-genetic cause of human male infertility involving 
spermatogenetic failure. Testing for these deletions in Japanese DNA 
samples using conventional sequence-tagged site (STS) probes occasionally 
led to considerable nonspecific or faint products in Japanese population. To 
improve the sensitivity and specificity of the detection of AZF microdeletions in 
the Japanese population, we developed a new molecular diagnostic kit.  
Methods: STS probes were reselected and the Luminex suspension array 
assay was performed. Validation was retrospectively carried out with 2,014 
DNA sequences with known microdeletions, which were divided into four 
categories.  
Results: Category-1 deletions corresponded to the conventional classification 
of AZF deletion are present in 83 men (4.2%), which can result in 
intrachromosomal homologous recombination. Kit data confirmed the 
presence of deletions of this type in DNA sequences known to harbor AZF 
deletions. Category-2 deletions involved cytogenetic abnormalities in 28 
(1.4%), while category-3 deletions in 759 (37.7%) were atypical classifications 
including gr/gr deletion. Since these deletions are thought to be due to 
palindromic units and non-homologous recombination, these microdeletions 
may impact the interpretation of some clinical findings. The rest of 1145 cases 




Conclusions: Our findings demonstrate that this new kit exhibits good 
sensitivity and specificity in Japanese men plus saving money and time. 
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Introduction 
Male factors leading to infertility may account for up to 40-50% of total infertile 
couples.1 The origin of male-factor infertility remains largely unexplained. In 
healthy males, infertility may have a number of unknown causes, including 
genetic disorders. Approximately 7% of infertile men harbor microdeletions of 
the Y chromosome that are not detectable with routine karyotype analyses.2 
Cytogenetic studies in infertile men have revealed a gene that controls 
spermatogenesis; this AZF is located on the Yq.3 Three spermatogenesis loci 
in Yq11 have been classified into three regions: AZFa, AZFb, and AZFc.4 
The euchromatic region of the Y chromosome is currently characterized by 
three structurally distinct features, the X-degenerated, X-transposed, and 
ampliconic sequences. The ampliconic region includes eight palindromes with 
pairs of duplicated amplicons in which the DNA sequences share more than 
99.9% homology.5 These amplicons and sub-amplicons can serve as 
substrates for structural genomic rearrangement. Thus, AZF deletions can 
result from intrachromosomal homologous recombination events between 
non-reciprocal homologous sequences.6 
From the clinical point of view, deletions in the AZF regions are the most 
common known molecular-genetic cause of human male infertility involving 
spermatogenetic failure.7 Thus, the molecular diagnosis of Y-chromosomal 
microdeletions should be routinely performed worldwide in the workup of male 
infertility in men with azoospermia or severe oligozoospermia. The importance 
of a molecular-genetics approach that includes the evaluation of AZF 
deletions must be emphasized for men considering assisted reproductive 
techniques including TESE, because this genetic defect is transmitted to their 
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sons, affecting their fertility.8 Furthermore, this information is useful for the 
avoidance of unnecessary surgical therapy. 
Nowadays, the gold standard for the diagnosis of microdeletions in the AZFa, 
AZFb, and AZFc regions utilizes PCR primers, including primers sY84, sY86, 
sY127, sY134, sY254, and sY255.9 When we previously tested Japanese 
patients using these eight probes, considerable nonspecific or faint bands 
were occasionally observed in the PCR products, particularly following the 
use of the sY254 and sY255 probes in the AZFc region. Re-evaluation 
frequently necessitated the use of several adjacent STS markers.10 
To improve the sensitivity and specificity of the detection of microdeletions in 
the Y chromosome, we developed a new kit for the detection of molecular Y-
chromosome deletions by re-selecting STS probes and carrying out multiplex 
target detection on the Luminex suspension array platform. Here we report 
the results of a retrospective evaluation of the new molecular Y-chromosome 
deletion kit using DNAs with previously determined genetic phenotypes. 
 
Materials and methods 
DNA sources and samples 
This study was approved by the Ethics Committee of the Kanazawa University 
Graduate School of Medical Science. All participants had granted informed 
consent for a previous study. Genomic DNA was sampled in a male infertility 
clinic and stored after diagnosing the presence or absence of Y-chromosomal 
microdeletions between 1999 April and 2012 December. This genetic 
diagnosis included the identification of AZF deletions. The samples were 
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anonymized and made available for research following approval by the 
appropriate ethics committee. 
 We retrospectively analyzed genomic DNA samples from 2,014 anonymized 
subjects who visited the clinic with male infertility as their chief complaint. 
Deletions in these DNA samples were confirmed using in-house detection 
methods. DNA samples from patients with Klinefelter syndrome or 
hypogonadotrophic hypogonadism were not included in the present 
investigation.  
In-house detection probes 
All DNA samples were screening for Y-chromosomal microdeletions 
according to the guidelines of the EAA and the EMQN. These guidelines 
recommend the following first-choice STS primers: two STSs in AZFa (sY86 
and sY84), two in AZFb (sY127 and sY134), and two in AZFc (sY254 and 
sY255).9 These STS probes previously yielded reproducible results. 
All DNA samples were evaluated for deletions using the following in-house 
STS probes: for AZFa, probes sY82, sY84, and sY86; for AZFb, probes 
sY1264, sY1235, sY1227, sY1228, sY117, sY280, sY127, sY134, sY135, 
sY258, sY142, and sY143; for AZFc, probes sY1161, sY1191, sY1197, 
sY1291, sY1125, sY1054, sY1206, sY1201, sY255, and sY254.11  
These probes were designed according to EAA/EMQN guidelines and 
produced with the UCSC Genome Bioinformatics and the GenBank database. 
The human reference sequence (UCSC version hg16, 17 and 18) was based 
on National Center for Biotechnology Information Build 34 (July 2003), 35 
(May 2004), 36 (Mar. 2006) produced by the International Human Genome 
Sequencing Consortium (http://genome.ucsc.edu/index.html).  
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All DNA samples were subjected to STS testing to confirm the presence or 
absence of deletions. 
STS probes in the GENOSEARCHTM AZF Deletion kit 
STS probes for the Y chromosome were chosen as markers of either single or 
double sequence copies using MSY Breakpoint Mapper 
(http://breakpointmapper.wi.mit.edu/) and UniSTS 
(http://www.ncbi.nlm.nih.gov/unists). Twenty-one STS probes were located on 
the Y chromosome. Probe sY757 (SOX3) served as a control probe for the X 
chromosome. The controls for the Yp were sY14 (SRY) and sY3118, and the 
controls for Yq were sY1251 and sY3159. Probes sY1251 and sY3159 were 
controls for the proximal and distal Y chromosome, respectively. Probes 
sY1324, sY1316, and sY1714 were used for the detection of AZFa deletions 
(Fig. 1). Fig. 2 depicts the locations (proximal to distal) of the following probes 
in the AZFb and AZFc regions: sY1024, sY1967, sY1309, sY3199, sY1233, 
sY3010, sY2990, sY1197, sY1191, sY1307, sY1291, sY2858, and sY1206. 
All of these probes are single-copy probes, with the exceptions of sY1967, 
sY1307, sY2858, and sY1206, which are present in two copies on the Y 
chromosome. 
Multiplex PCR  
Genomic DNA was prepared from patient peripheral blood lymphocytes with several 
commercial extraction kits according to the manufacturers’ protocols. PCR was 
performed in 25 μL of PCR buffer (20 mM Tris-HCl (pH 8.3), 30 mM KCl, 2.5 mM 
MgCl2) containing 200 μM of each deoxyribonucleoside triphosphate, with 0.625 U 
TaqDNA Polymerase (Roche Diagnostics, Mannheim, Germany), 50-100 ng of 
genomic DNA, and each primer at a final concentration of 0.2 μM. All PCR primers 
were biotinylated. The PCR profile consisted of one cycle of 2 min at 93 °C, followed 
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by 45 cycles of 1 min at 93 °C, 30 s at the annealing temperature of 59 °C, and 60 s 
at 70 °C, with a final cycle of 5 min at 70 °C. Amplifications were carried out on a 
GeneAmp 9700 thermal cycler (Applied Biosystems, Foster City, CA, USA). 
Luminex xMAP technology 
Results from the GENOSEARCHTM AZF Deletion kit (MBL, Nagoya, Japan) of 
development stage were confirmed via Luminex xMAP technology. To detect 
deletions in the AZF regions, amplification by sequence-specific probes and 
hybridization of each solid phase-binding STS were performed. The probes were 15-
30mers that encompassed the sequence in the amplification region for each set of 
biotinylated primers. PCR products were mixed with the microbeads; the probes 
bound these beads, enabling multiple hybridization reactions in the same tube. 
Each 30 μL hybridization reaction consisted of 5 μL PCR product, 20 μL 1x 
hybridization buffer (75 mM Tris-HCl (pH 8.0), 0.6 mM ethylenediaminetetraacetic 
acid (pH 8.0), 0.15% surfactant, 4.5 M tetramethylammonium chloride), and 5 μL 
probe-binding beads. The hybridization reactions were carried out at 95 °C for 2 min 
and 52 °C for 30 min. After the incubation, the beads were washed twice with 70 μL 
of phosphate-buffered saline (PBS) -Tween with centrifugation for 1 min at 2,000 x g. 
After washing, the samples were labeled with streptavidin-phycoerythrin and 
incubated at 52 °C for 15 min. This hybridization between the PCR- amplified product 
and the probes on the fluorescently labeled beads allowed the quantification of the 
number of probes corresponding to each STS marker following flow cytometry based 
on the Luminex system (Luminex Corp., Austin, TX, USA). Each measurement 
encompassed at least 50 beads; the median phycoerythrin intensity was considered. 
To determine the presence of deletions, we set individual cutoff values for the 
fluorescence intensity of each bead-bound probe; if the intensity was below the cut-
off, the sequence was defined as harboring a deletion. Samples from healthy female 
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subjects and a negative control of distilled water were used to determine the 
individual cutoffs.  
Validation  
We tested 2,014 samples with our in-house kit. Our laboratory performed 




General results and probe characteristics 
The current investigation evaluated 2,014 DNA samples. The mean subject 
age was 35.0±7.0 years (range 19-72 years). All DNA samples that had 
previously been determined to harbor deletions associated with a chief 
complaint of male infertility were analyzed. The deletions were classified into 
40 patterns according to differences in adjoining patterns (Supplementary Fig. 
1). 
Here we present broad genetic information about microdeletions of the Y 
chromosome that are pertinent for clinicians or researchers investigating 
Japanese populations. For convenience, we grouped the results from our kit 
into four categories. Probe sY1291 is especially pertinent for Japanese 
populations; this marker was previously used for the detection of both the 
gr/gr (green-red sub-amplicon) deletion and Y haplogroup marker D.12 13 One-
third of Japanese males carry the deletion probed by sY1291.14-16 Therefore, 
the deletion of the sequence probed by sY1291would not be taken into 
account during the evaluation of all but gr/gr deletions (pattern 39). 
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Furthermore, a pair of palindromes was duplicated in the set of DNA samples 
included in this investigation, yielding double hybridization of STS probes, for 
example for probes sY1967, sY1307, sY2858, and sY1206. These probes 
may not always detect the deletion of the duplicated region when 
implemented in a PCR-based evaluation. When noncontiguous deletions were 
observed, such as in patterns 7, 8, 11, 14, 15, 18, 25, 26, 31, 32, 35, and 36, 
we avoided non-sequential regions when designating the deletion location 
(Supplementary Fig. 1, 1*). 
Categorization of deletion patterns and number in a Japanese 
population 
We classified the detected deletion patterns into the following four categories: 
category 1, classical AZF microdeletions; category 2, Y chromosome long-
arm terminal deletions, including heterochromatin deletion; category 3, 
subclassification of Yq microdeletions; category 4, miscellaneous deletions 
(polymorphisms).  
Category 1 deletions in 83 men (4.2%), category 2 deletion in 28 (1.4%) and 
category 3 deletion in 759 (37.7%) including gr/gr deletion were indicated. The 
rest 1145 cases (56.8%) were assigned to category 4 in this study.  
For category-1 deletions, we divided the conventional concept of the 
AZF region into regions AZFa, AZFb (P5/proximal P1), AZFb+c (P5/distal P1; 
recombination between palindrome 5 and distal palindrome 1), and AZFc 
(b2/b4) (Fig. 2a, d). The P5/distal P1 recombination eliminated the intervening 
homologous sequences. The ‘b2/b4’ categorization captures a recombination 
event between sub-amplicons b2 and b4 (Fig. 2b, d). This deletion category is 
based on the EAA/EMQN guidelines.17 This conventional classification 
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encompasses the probes indicated in Fig. 2c, and yielded the corresponding 
patterns reported in Fig. 3. There were 7, 1, 12, and 63 samples that harbored 
deletions in AZFa, AZFb, AZFb+c, and AZFc, respectively (Fig. 3). All AZF 
deletions were confirmed by in-house STS probes. Therefore, the sensitivity 
and the specificity of our new kit were 100% for the detection of category-1 
AZF deletions. 
Category-1 deletions result in the recombination of the intervening 
homologous sequences between duplicated palindromes (Fig. 2d). Thus, the 
term ‘microdeletion’ implies that a part of the deletion of the inner euchromatin 
region of Yq is due to homologous recombination. We suggest differentiating 
microdeletion from partial Yq terminal deletion like following category-2 
deletions. 
With regards to category-2 deletions, probe sY3159 is located the end 
of the Yq euchromatin (Fig. 1). Deletion of this sequence may be 
accompanied by elimination of the distal Y chromosome end, including the 
heterochromatin.  Patterns 3 (Yq I), 6 (Yq II), 13 (Yq III), 17 (Yq IV), 19 (Yq V) 
and 29 (Yq VI) were deleted from the distal Yq (Fig. 4). These deletions were 
also detected by evaluating karyotype analyses (Supplementary Table 1). Yq 
terminal deletions I-VI appeared in 1, 4, 6, 5, 3, and 3 samples respectively. 
Interestingly, all patients carrying pattern 2 were diagnosed as XX male.  
According to deletions of sY3159, patterns 37 indicated a normal karyotype. 
One sample displayed pattern 38, deletion of sY3159. This karyotype was 46, 
XY (Fig. 6). Deletion of sY3159 alone was classified as a polymorphism 
present in the Japanese population; therefore, pattern 25 was classified as 
Ym-8 (Fig. 5). 
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Category 3 included atypical Y microdeletions (Fig. 5). These deletions 
most likely involved palindromic units, unlike the intra-chromosomal non-
homologous recombination that underlies category-1 deletions. Although few 
category-3 deletions were detected (Fig. 5; Ym-1 to Ym-7, Ym-9, Ym-10 and 
Ym-13 deletions occurred in 2, 1, 2, 1, 1, 5, 1, 2, 1 and 2 samples, 
respectively), these deletions are of clinical significance and are the focus of a 
separate investigation. 
In contrast, patterns 25 and 26 (Ym-8), pattern 28 and 32 (Ym-11), and 
pattern 39 (Ym-12) indicate partial deletions of AZFc due to homologous 
recombination between sub-amplicons b1/b3, b2/b3, and gr/gr, respectively 
(Fig. 5). These deletions have already been investigated.18-20 There were 18, 
33, and 690 samples in this study with Ym-8, Ym-11, and Ym-12 deletions, 
respectively.  
For category-4 deletions, patterns 12, 22, 23, 35, 36, 37 and 38 
occurred in 5, 1, 1, 1, 2, 1, and 1 samples, respectively (Fig. 6). Although 
probe sY1291 is neglected absence or presence of band, these group have 
only one deletion. Therefore, we classified these deletions as polymorphisms 
specific to Japanese populations. 
 
Discussion 
In Japan, all available genetic testing for AZF deletions is based on the 
Promega Y Chromosome AZF Analysis System (version 2.0; Promega, 
Madison, WI, USA). Previously, numerous nonspecific bands were 
occasionally observed with these PCR products, probably because this 
system was optimized for Caucasian DNAs or different thermocyclers. 
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In this study, we evaluated the performance of the GENOSEARCHTM AZF 
Deletion kit, which is based on Luminex xMAP technology and identifies 
samples harboring deletions of sequences represented by STS probes. An 
automated multiplex bead-array system provided high-throughput 
identification of PCR products.21  
Currently, up to 100 spectrally distinct fluorescence-labeled beads are 
available for multiplex target detection on the Luminex suspension microarray 
platform. This array system saves labor, money, and time22, 23 and can be 
implemented daily with acceptable sensitivities and specificities. Its routine 
use may underlie the development and implementation of assays to detect 
genetic deletions in a timely manner. 
Our molecular assays were performed on DNA samples that had undergone 
several freeze/thaw cycles. Although deletion assays might be improved by 
further probe optimization, changes in the probe sequences could have 
deleterious effects on other targets in the multiplexed reaction. Therefore, the 
GENOSEARCHTM AZF Deletion kit provides a practical solution in the clinical 
setting for rapidly screening and detecting AZF deletions.  
We detected excellent specificities and favorable sensitivities in comparison to 
the use of conventional STS probes for the detection of AZF deletions. 
Moreover, this kit is compatible with rapid, automated, high-throughput 
procedures; simultaneous detection strategies reduced the manpower, 
reagent volumes, and specimen volumes required for use of the 
GENOSEARCHTM AZF Deletion kit. 
From the clinical point of view, microdissection TESE via microscopy is 
currently recognized as the best way of retrieving sperm in men with non-
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obstructive azoospermia. Compared with conventional TESE, microdissection 
TESE has a higher sperm retrieval rate and is safer.24 Genetic testing for Y-
chromosome microdeletions is of prognostic significance for TESE.  
Men with complete deletions of the AZFa or AZFb region or absence of the 
AZFb+c region have no chance of sperm retrieval during microdissection 
TESE25 and are not recommended to undergo this procedure. Many 
unnecessary TESE procedures are carried out, motivating the need for 
reliable genetic testing. 
Category-1 deletions correspond to the AZF deletions referred to by the 2004 
EAA/EMQN guidelines and are sufficient to make a diagnosis for male 
infertility. Our results indicate that the GENOSEARCHTM AZF Deletion kit may 
be a suitable replacement for conventional STS probes for Japanese 
populations. When deletions in category 2 are detected, cytogenetic assays 
should be performed for determining the patient’s karyotype. 
It should be emphasized that microdeletions, excluding the Ym-8, Ym-11 and 
Ym-12 microdeletions in category 3, are atypical classifications that have not 
been rigorously investigated. Therefore, the presence of these microdeletions 
may impact the interpretation of some clinical findings, although this scenario 
is expected to occur rarely. The accurate detection of these microdeletions 
was the most striking feature of the GENOSEARCHTM AZF Deletion kit. 
In conclusion, we have described the development of the GENOSEARCHTM 
AZF Deletion kit for the detection of a panel of AZF deletions; this technology 
includes the use of Luminex xMAP arrays. This new kit provided a routine tool 
for the diagnosis of AZF deletions in patients accessing a male infertility clinic 
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Fig. 1. Location of STS probes for control regions and for the AZFa region for 
use with the GENOSEARCH® AZF Deletion kit. Black, pseudoautosomal 
region; light grey, euchromatin; dark grey, the heterochromatic region of the Y 
chromosome. Probes SRY and sY3118 were Yp controls. Probe sY1251 was 
a control for the Yq centromere, and probe sY3159 was a control for the Yq 
euchromatin. 
 
Fig. 2. AZFb and AZFc regions in the Y chromosome. (a) Palindrome (P) 
structure in the Y chromosome. Rightward-facing arrows denote the 3’ to 5’ 
direction. (b) Sub-amplicon structure of the AZFc region. Identical pairs of 
amplicons appear in the same color. yel, yellow sub-amplicon; b, blue sub-
amplicon; t, tan sub-amplicon; r, red sub-amplicon; gr, grey sub-amplicon; g, 
green sub-amplicon. (c) Locations of the probes used with the 
GENOSEARCH® AZF Deletion kit. (d) The AZFb and AZFc regions. 
Microdeletions in AZFb and AZFc result from nonreciprocal intrachromosomal 
recombination events between homologous sequences. 
 
Fig. 3. Classical AZF microdeletions (category 1). Within the body of the 
figure, ‘0’ denotes ‘absence,’ ‘1’ denotes ‘presence,’ and ‘1*’ denotes 
duplicated copies of a DNA sequence. Black arrows highlight data from the 




Fig. 4. Y chromosome long-arm terminal deletions, including heterochromatin 
(category 2). Yp, Y chromosome long arm; Yq, Y chromosome short arm. 
Other notation is as in Fig. 3. 
 
Fig. 5. Y chromosome microdeletion (subclassification; category 3). Ym, Y 
chromosomal microdeletions. Other notation is as in Fig. 3. 
 
Fig. 6. Miscellaneous deletions (category 4). Notation is as in Fig. 3. 
 
 
 Supplementary Material. 
Supplemetary Fig. 1 
All raw deletion data in accordance with various patterns. Within the body of 
the figure, ‘0’ denotes ‘absence,’ ‘1’ denotes ‘presence,’ and ‘1*’ denotes 
duplicated copies of a DNA sequence. Possible deletions are colored grey. 
Notation is as in Fig. 3 
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4 5 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 AZFa
5 2 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 AZFa
7 2 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1* 0 0 0 1 1 AZFb+c (P5/distal P1)
8 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1* 0 1 1 1 1 1 1 AZFb (P5/proximal P1)
14 10 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1* 0 0 0 1 1 AZFb+c (P5/distal P1)
30 62 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 1 AZFc (b2/b4)
31 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1* 0 0 0 1 1 AZFc (b2/b4)
Fig.3
AZF: Azoospermia factor, P: Palindrome, b: b sub-amplicon
Fig.4
Yp: Y chromosome short arm, Yp: Y chromosome long arm, AZF: Azoospermia factor 




















































































































































































1 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Whole Y
2 4 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Yp
3 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Yq I （distal to AZFa)
6 4 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Yq II （distal to AZFb)
13 6 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Yq III （distal to AZFb)
17 5 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 Yq IV （distal to AZFb)
19 3 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 Yq V （distal to AZFb)
29 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 Yq VI （distal to AZFb)
Fig.5




















































































































































































9 1 1 1 1 1 1 1 1 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 Ym-2 (P5+P4)
10 1 1 1 1 1 1 1 1 0 0 0 0 1 1 1 1 1 1 1 0 1 1 1 1 1 1 Ym-1 (P5+P4)
11 1 1 1 1 1 1 1 1 0 1* 0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 Ym-1 (P5+P4)
15 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1* 0 1 1 1 1 1 1 Ym-3 (AZFb partial)
16 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 Ym-3 (AZFb partial)
18 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1* 0 1 1 1 1 1 1 Ym-4 (AZFb partial)
20 5 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1 Ym-6 (P3+P2+P１)
21 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 Ym-5 (P3)
24 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 Ym-7 (P3+P2+P１)
25 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1* 0 1 1 1 1 1 0 Ym-8 (b1/b3)
26 17 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1* 0 1 1 1 1 1 1 Ym-8 (b1/b3)
27 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 Ym-9 (P3)
28 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 1 1 1 1 1 Ym-10 (P3)
32 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1* 0 1 1 1 1 1 1 Ym-11 (b2/b3)
33 32 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 Ym-11 (b2/b3)
34 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 1 Ym-13 (P1)
39 690 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 Ym-12 (gr/gr)
P: Palindrome, AZF: Azoospermia factor 
Fig.6




















































































































































































12 5 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 polymorphism
22 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 1 polymorphism
23 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 polymorphism
35 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1* 1* 0 1 1 1 polymorphism
36 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1* 0 1 1 polymorphism
37 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0 polymorphism
38 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 polymorphism
40 1134 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 no deletion



















































































































































































1 2 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
2 4 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
3 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
4 5 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1
5 2 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
6 4 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
7 2 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1* 0 0 0 1 1
8 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1* 0 1 1 1 1 1 1
9 1 1 1 1 1 1 1 1 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1
10 1 1 1 1 1 1 1 1 0 0 0 0 1 1 1 1 1 1 1 0 1 1 1 1 1 1
11 1 1 1 1 1 1 1 1 0 1* 0 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1
12 5 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
13 6 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
14 10 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1* 0 0 0 1 1
15 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1* 0 1 1 1 1 1 1
16 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1
17 5 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
18 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 1* 0 1 1 1 1 1 1
19 3 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0
20 5 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 1
21 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1 1
22 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 1 1
23 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1
24 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1
25 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1* 0 1 1 1 1 1 0
26 17 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1* 0 1 1 1 1 1 1
27 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 1 1 1 1 1 1 1
28 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1 1 0 1 1 1 1 1 1
29 3 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0
30 62 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 1
31 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1* 0 0 0 1 1
32 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1* 0 1 1 1 1 1 1
33 32 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1
34 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 1
35 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 1* 1* 0 1 1 1
36 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1* 0 1 1
37 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 0
38 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0
39 690 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1
40 1134 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Yp deletion Yq I Yq II Yq III Yq IV Yq V Yq VI
46, XX male (4) mos 46X, del(Y) (?q11.23)
[24]/ 45, X[6] (1)
mos 46, XYq-? [44]/
45, X[6] (1)
46, Xdel(Y) (?q11.23) (1) mos 46, XYq- [44]/ 45, X [6]
(1)
mos 45, X [11}/ 46, Xdel(q11.2)
[89] (1)
46, Xdel (Y) (q11.2) (1)
mos 45, X [4]/ 46XY
[16] (1)
46, Xidic(Y) (?q11.23) (1) 46, XYq-? (2) mos 46, X+mar [37]/ 45, X [13]
(1)
46, X+mar (2)
N/A (2) mos 46, Xidic(Y)（ｑ11.2）/
46, Xdel（Yq11.2）/ 45, X (1)
mos 46, X+mar [23]/ 46, Xdel
(Y) (q11.2) [20]/ 45, X [7] (1)
mos 46, Xdel(Y) (q11.2) [29] /
46, Xidic(Y)(q11.2) [10]/ 45，X
[11] (1)n/a (2) 46, Xdel (Y) (q?11.23) (1)
mos 46, Xidic(Y) (q11.2)/ 45, X
(1)
Supplementary Table 1 Chromosomal aberrations in category-2 in this study
karyotype (sample no), n/a, not available
